122 related articles for article (PubMed ID: 12377663)
1. The importance of the VEGF-load in platelets in cancer patients.
Salgado R; Benoy I; van Marck E; Vermeulen P; Dirix L
Ann Oncol; 2002 Oct; 13(10):1689-90. PubMed ID: 12377663
[No Abstract] [Full Text] [Related]
2. Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients.
Bachelot T; Ray-Coquard I; Menetrier-Caux C; Rastkha M; Duc A; Blay JY
Br J Cancer; 2003 Jun; 88(11):1721-6. PubMed ID: 12771987
[TBL] [Abstract][Full Text] [Related]
3. Serum interleukin 6, plasma VEGF, serum VEGF, and VEGF platelet load in breast cancer patients.
Benoy I; Salgado R; Colpaert C; Weytjens R; Vermeulen PB; Dirix LY
Clin Breast Cancer; 2002 Jan; 2(4):311-5. PubMed ID: 11899364
[TBL] [Abstract][Full Text] [Related]
4. Determination of vascular endothelial growth factor (VEGF) in circulating blood: significance of VEGF in various leucocytes and platelets.
Werther K; Christensen IJ; Nielsen HJ
Scand J Clin Lab Invest; 2002; 62(5):343-50. PubMed ID: 12387579
[TBL] [Abstract][Full Text] [Related]
5. Platelet: transporter of vascular endothelial growth factor.
Verheul HM; Hoekman K; Luykx-de Bakker S; Eekman CA; Folman CC; Broxterman HJ; Pinedo HM
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2187-90. PubMed ID: 9815613
[TBL] [Abstract][Full Text] [Related]
6. Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging?
George ML; Eccles SA; Tutton MG; Abulafi AM; Swift RI
Clin Cancer Res; 2000 Aug; 6(8):3147-52. PubMed ID: 10955796
[TBL] [Abstract][Full Text] [Related]
7. Serum concentrations of vascular endothelial growth factor in advanced non-small cell lung cancer.
Trapé J; Buxó J; de Olaguer JP
Clin Chem; 2003 Mar; 49(3):523-5. PubMed ID: 12600977
[No Abstract] [Full Text] [Related]
8. Serum vascular endothelial growth factor load and interleukin-6 in cancer patients.
O'Byrne KJ; Dobbs N; Harris AL
Br J Cancer; 2000 Jun; 82(11):1895-6. PubMed ID: 10839310
[No Abstract] [Full Text] [Related]
9. Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients.
Salgado R; Vermeulen PB; Benoy I; Weytjens R; Huget P; Van Marck E; Dirix LY
Br J Cancer; 1999 May; 80(5-6):892-7. PubMed ID: 10360671
[TBL] [Abstract][Full Text] [Related]
10. Prognostic role of serum vascular endothelial growth factor, basic fibroblast growth factor and nitric oxide in patients with colorectal carcinoma.
Akbulut H; Altuntas F; Akbulut KG; Ozturk G; Cindoruk M; Unal E; Icli F
Cytokine; 2002 Nov; 20(4):184-90. PubMed ID: 12543084
[TBL] [Abstract][Full Text] [Related]
11. Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor.
Kim HK; Song KS; Park YS; Kang YH; Lee YJ; Lee KR; Kim HK; Ryu KW; Bae JM; Kim S
Eur J Cancer; 2003 Jan; 39(2):184-91. PubMed ID: 12509950
[TBL] [Abstract][Full Text] [Related]
12. Tumour markers as early predictors of response to chemotherapy in advanced colorectal carcinoma.
Berglund A; Molin D; Larsson A; Einarsson R; Glimelius B
Ann Oncol; 2002 Sep; 13(9):1430-7. PubMed ID: 12196369
[TBL] [Abstract][Full Text] [Related]
13. Quantitative correlation of serum levels and tumor expression of vascular endothelial growth factor in patients with hepatocellular carcinoma.
Poon RT; Lau CP; Cheung ST; Yu WC; Fan ST
Cancer Res; 2003 Jun; 63(12):3121-6. PubMed ID: 12810638
[TBL] [Abstract][Full Text] [Related]
14. Correspondence re: M.L. George [correction of H.L. George] et al., Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging? Clin. Cancer Res., 6: 3147-3152, 2000.
Gunsilius E; Tschmelitsch J; Petzer AL
Clin Cancer Res; 2001 Feb; 7(2):443-4. PubMed ID: 11234902
[No Abstract] [Full Text] [Related]
15. Prognostic importance of serum vascular endothelial growth factor in relation to platelet and leukocyte counts in human renal cell carcinoma.
Jacobsen J; Grankvist K; Rasmuson T; Ljungberg B
Eur J Cancer Prev; 2002 Jun; 11(3):245-52. PubMed ID: 12131658
[TBL] [Abstract][Full Text] [Related]
16. Potential role of platelets in endothelial damage observed during treatment with cisplatin, gemcitabine, and the angiogenesis inhibitor SU5416.
Kuenen BC; Levi M; Meijers JC; van Hinsbergh VW; Berkhof J; Kakkar AK; Hoekman K; Pinedo HM
J Clin Oncol; 2003 Jun; 21(11):2192-8. PubMed ID: 12775746
[TBL] [Abstract][Full Text] [Related]
17. [Determination of vascular endothelial growth factor (VEGF) concentration in serum of patients with colorectal carcinoma].
Broll R; Erdmann H; Windhövel U; Duchrow M; Strik MW
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):315-8. PubMed ID: 14518267
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of VEGF do not correlate with the severity of multiple myeloma.
Jakob C; Zavrski I; Heider U; Langelotz C; Eucker J; Possinger K; Sezer O
Br J Haematol; 2002 Oct; 119(1):276; author reply 276-7. PubMed ID: 12358939
[No Abstract] [Full Text] [Related]
19. Prognostic value of VEGF levels for ovarian hyperstimulation.
Bussen S; Dietl J
Fertil Steril; 2003 Sep; 80(3):681-2; author reply 682. PubMed ID: 12969739
[No Abstract] [Full Text] [Related]
20. Kinetics of postoperative serum vascular endothelial growth factor (VEGF)--can it be used to predict curative resections in colorectal cancer?
Kumar H; Heer K; Duthie GS; Monson JR
Anticancer Res; 2002; 22(6B):3717-22. PubMed ID: 12552982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
